Plus the predictive value of hPEBP4 in the radioresistance of rectal cancer with clinical tumor samples in our recent report [12], we believe hPEBP4 may be a potential target to enhance the sensitivity of radiotherapy for rectal cancer. The gene discussed is PEBP4; the disease is neoplasm.